notoginsenoside R 1,
notoginsenoside R1,
sanchinoside R1,
Notoginsenoside R1,
80418-24-2,
Sanchinoside R1,
notoginsenoside-R1,
UNII-Z62692362Z,
CHEBI:77149,
MFCD00210535,
Z62692362Z,
(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-xylopyranosyl-beta-D-glucopyranoside,
AC1L9BYK,
O-Acetylseudolaric acid C,
CHEMBL507115,
Notoginsenoside?R1,
Sanqi glucoside R1,
C47H80O18,
(20S)-ginsenoside R1,
HY-N0615,
AKOS025311471,
ZINC238809173,
CS-4167,
Notoginsenoside R1, >=98% (HPLC),
Notoginsenoside R1, analytical standard,
AN-36396,
beta-D-Glucopyranoside, (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-xylopyranosyl-,
CC-33084,
AB0019823,
N1607,
V0341,
C08961,
418N242,
C-23582,
Q-100835,
(2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,1,
b-D-Glucopyranoside,(3b,6a,12b)-20-(b-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-b-D-xylopyranosyl-,
Pseudolaric acid B,
Notoginsenoside R 1,
(-)-Pseudolaric acid B,
CID441934,
ACN-035591,
C47-H80-O18,
C072936,
Notoginsenoside R1, 98%, from Panax notoginseng (Burk.)F.H.Chen - 5MG 5mg,
(2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol,